Martha Lenis
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST-FUS Phase 2 Trial).
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: April 02, 2021
An MDS-specific frailty index based on cumulative deficits adds independent prognostic information to clinical prognostic scoring.
Journal: Leukemia
Published: July 31, 2019
The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study.
Journal: Leukemia research
Published: September 05, 2018
A predictive model of response to erythropoietin stimulating agents in myelodysplastic syndrome: from the Canadian MDS patient registry.
Journal: Annals of hematology
Published: June 15, 2017
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient-related factors and measuring from time of first red blood cell transfusion dependence: an MDS-CAN analysis.
Journal: British journal of haematology
Published: March 18, 2017
Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Journal: Vox sanguinis
Published: June 26, 2016
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study.
Journal: British journal of haematology
Published: November 12, 2015
Lenalidomide and metronomic melphalan for CMML and higher risk MDS: a phase 2 clinical study with biomarkers of angiogenesis.
Journal: Leukemia research
Published: January 09, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026